Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer

BACKGROUND: The presence of T cells and suppressive myeloid cells in epithelial ovarian cancer (EOC) correlate with good and bad clinical outcome, respectively. This suggests that EOC may be sensitive to adoptive cell therapy with autologous tumor-infiltrating lymphocytes (TIL), provided that immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Verdegaal, Els M E, Santegoets, Saskia J, Welters, Marij J P, de Bruin, Linda, Visser, Marten, van der Minne, Caroline E, de Kok, Pita M, Loof, Nikki M, Boekestijn, Sanne, Roozen, Inge, Westra, Inge M, Meij, Pauline, Van der Burg, Sjoerd H, Kroep, Judith R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649798/
https://www.ncbi.nlm.nih.gov/pubmed/37949617
http://dx.doi.org/10.1136/jitc-2023-007697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649798/
https://www.ncbi.nlm.nih.gov/pubmed/37949617
http://dx.doi.org/10.1136/jitc-2023-007697

Ejemplares similares